Download PDF
CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2019; 7(02): 43-44
DOI: 10.1055/s-0039-3400213
Editorial

Equipoise Is a Slippery Eel

Sanjay Kalra
1   Department of Diabetology, DiaCare Diabetes Clinic, Ahmedabad, Gujarat, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Introduction

The word “equipoise” is a versatile one. Used as a noun, it implies a “balance of forces or interests,” or a “counterbalance or balancing force.” As a verb, it is used to convey the act of balancing or counterbalancing.[1] The use of this word, however, has fallen dramatically over the past century. Is this because the concept of equipoise is difficult to achieve?

In this editorial, we enumerate and discuss the domains of equipoise, as related to diabetes care ([Table 1]), and wonder if equipoise will always be a slippery eel.

Table 1

Equipoise in diabetes

Related to the patient

• Emotional equipoise

• Glycemic equipoise

• Vasculometabolic equipoise

Related to the professional

• Emotional equipoise

• Professional equipoise

Related to family/community

• Community equipoise

Related to interaction and treatment

• Therapeutic equipoise

• Information equipoise

• Equipoised intrusion

Related to cardiovascular trials

• Glycemic equipoise


Publication History

Article published online:
30 March 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Equipoise. https://www.merriam-webster.com/dictionary/equipoise. Accessed July 10, 2019
  • 2 Elwyn G, Edwards A, Kinnersley P, Grol R. Shared decision making and the concept of equipoise: the competences of involving patients in healthcare choices. Br J Gen Pract 2000; 50 (460) 892-899
    PubMedGoogle Scholar
  • 3 Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987; 317 (03) 141-145
    CrossrefPubMedGoogle Scholar
  • 4 Kalra S, John M, Unnikrishnan AG. Glycemic equipoise. Indian J Endocrinol Metab 2017; 21 (01) 18-20
    CrossrefPubMedGoogle Scholar
  • 5 Kalra S, Joshi A, Kalra B. et al. Bhagavad Gita for the physician. Indian J Endocrinol Metab 2017; 21 (06) 893-897
    CrossrefPubMedGoogle Scholar
  • 6 Kalra S, Baruah MP, Sahay R, Kishor K. Pentads and hexads in diabetes care: numbers as targets; numbers as tools. Indian J Endocrinol Metab 2017; 21 (06) 794-796
    CrossrefPubMedGoogle Scholar
  • 7 John M, Gopalakrishnan Unnikrishnan A, Kalra S, Nair T. Cardiovascular outcome trials for anti-diabetes medication: a holy grail of drug development?. Indian Heart J 2016; 68 (04) 564-571
    CrossrefPubMedGoogle Scholar
  • 8 Kalra S, Das AK, Baruah MP. et al. Euthymia in diabetes: clinical evidence and practice-based opinion from an international expert group. Diabetes Ther 2019; 10 (03) 791-804
    CrossrefPubMedGoogle Scholar
  • 9 Kalra S, Unnikrishnan AG, Baruah MP. Interaction, information, involvement (the 3I strategy): rebuilding trust in the medical profession. Indian J Endocrinol Metab 2017; 21 (02) 268-270
    CrossrefPubMedGoogle Scholar